Adrián Sánchez‐Montalvá

Randomized Trial of Posaconazole and Benznidazole for Chronic Chagas' Disease

Israel Molina, Jordi Gómez i Prat, Fernando Salvador et al. · New England Journal of Medicine · 2014 · 620 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacology +13

Benznidazole and Posaconazole in Eliminating Parasites in Asymptomatic  T. Cruzi Carriers

Carlos A. Morillo, Hetty Waskin, Sergio Sosa‐Estáni et al. · Journal of the American College of Cardiology · 2017 · 315 citations · Full text

Veterinary Medicine, Biology, Infectious Diseases +12

Tuberculosis, COVID-19 and migrants: Preliminary analysis of deaths occurring in 69 patients from two cohorts

I. Motta, Rosella Centis, Lia D’Ambrosio et al. · Pulmonology · 2020 · 249 citations · Full text

Public Health, Health Sciences, Infectious Diseases +16

The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies

Jérémy Manry, Paul Bastard, Adrian Gervais et al. · Proceedings of the National Academy of Sciences · 2022 · 193 citations · Full text

Life Sciences, Immunology, Infectious Diseases +15

Toxic Profile of Benznidazole in Patients with Chronic Chagas Disease: Risk Factors and Comparison of the Product from Two Different Manufacturers

Israel Molina, Fernando Salvador, Adrián Sánchez‐Montalvá et al. · Antimicrobial Agents and Chemotherapy · 2015 · 107 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13